首页> 外文期刊>The British journal of psychiatry : >Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis
【24h】

Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis

机译:首次发作性精神病后2年,大麻和兴奋剂疾病以及再次入院

获取原文
           

摘要

Background Few studies have examined the impact of stimulant use on outcome in early psychosis. Ceasing substance use may lead to positive outcomes in psychosis. Aims To examine whether baseline cannabis or stimulant disorders and ongoing drug use predict readmission within 2 years of a first psychosis admission. Method Predictors of readmission were examined with Cox regression in 7269 people aged 15-29 years with a first psychosis admission. Results Baseline cannabis and stimulant disorders did not predict readmission. A stimulant disorder diagnosis prior to index psychosis admission predicted readmission, but a prior cannabis disorder diagnosis did not. Ongoing problem drug use predicted readmission. The lowest rate of readmission occurred in people whose baseline drug problems were discontinued. Conclusions Prior admissions with stimulant disorder may be a negative prognostic sign in first-episode psychosis. Drug use diagnoses at baseline may be a good prognostic sign if they are identified and controlled.
机译:背景很少有研究检查兴奋剂使用对早期精神病患者预后的影响。停止使用毒品可能导致精神病的积极结果。目的:检查基线大麻或兴奋性疾病以及持续用药是否能预测首次精神病患者入院后两年内再次入院。方法采用Cox回归方法对7269名首次精神病入院的人的再入院率进行Cox回归分析。结果基线大麻和兴奋性疾病不能预测再次入院。入院精神病患者之前进行的兴奋性疾病诊断可预测再次入院,但先前的大麻疾病诊断则不能。持续存在的问题药物使用可预测再次入院。再入院率最低的人群是基线药物问题停药的人群。结论先前患有兴奋性疾病的入院可能是首发精神病的阴性预后征兆。如果能够确定和控制基线的药物使用诊断,则可能是良好的预后征兆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号